Chronic myelogenous leukemia: ESMO clinical recommendations for the diagnosis, treatment and follow-up
- PMID: 18456772
- DOI: 10.1093/annonc/mdn091
Chronic myelogenous leukemia: ESMO clinical recommendations for the diagnosis, treatment and follow-up
Similar articles
-
Chronic myelogenous leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.Ann Oncol. 2009 May;20 Suppl 4:105-7. doi: 10.1093/annonc/mdp143. Ann Oncol. 2009. PMID: 19454424 Review. No abstract available.
-
ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of chronic myelogenous leukemia (CML).Ann Oncol. 2005;16 Suppl 1:i52-3. doi: 10.1093/annonc/mdi807. Ann Oncol. 2005. PMID: 15888754 No abstract available.
-
Chronic myelogenous leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.Ann Oncol. 2007 Apr;18 Suppl 2:ii51-2. doi: 10.1093/annonc/mdm035. Ann Oncol. 2007. PMID: 17491046 No abstract available.
-
Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol. 2010 May;21 Suppl 5:v165-7. doi: 10.1093/annonc/mdq201. Ann Oncol. 2010. PMID: 20555071 No abstract available.
-
[Chronic myeloid leukemia--contemporary diagnosis and treatment possibilities].Pol Arch Med Wewn. 2001;105 Suppl:391-4. Pol Arch Med Wewn. 2001. PMID: 12412274 Review. Polish. No abstract available.
Cited by
-
Suboptimal response to or failure of imatinib treatment for chronic myeloid leukemia: what is the optimal strategy?Mayo Clin Proc. 2009 Feb;84(2):161-9. doi: 10.4065/84.2.161. Mayo Clin Proc. 2009. PMID: 19181650 Free PMC article. Review.
-
Monitoring response and resistance to treatment in chronic myeloid leukemia.Curr Oncol. 2011 Apr;18(2):e71-83. doi: 10.3747/co.v18i2.391. Curr Oncol. 2011. PMID: 21505592 Free PMC article.
-
miRNAs as Biomarkers in Chronic Myelogenous Leukemia.Drug Dev Res. 2015 Sep;76(6):278-85. doi: 10.1002/ddr.21266. Epub 2015 Aug 18. Drug Dev Res. 2015. PMID: 26284455 Free PMC article. Review.
-
Population-Based Testing and Treatment Characteristics for Chronic Myelogenous Leukemia.J Registry Manag. 2016 Fall;41(3):134-142. J Registry Manag. 2016. PMID: 28121314 Free PMC article.
-
Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules.Front Oncol. 2024 Jan 8;13:1239042. doi: 10.3389/fonc.2023.1239042. eCollection 2023. Front Oncol. 2024. PMID: 38260856 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical